Literature DB >> 16162269

Differential effects of CpG-DNA in Toll-like receptor-2/-4/-9 tolerance and cross-tolerance.

Alexander H Dalpke1, Martin D Lehner, Thomas Hartung, Klaus Heeg.   

Abstract

Lipopolysaccharide (LPS) tolerance is a state of refractoriness towards a second stimulation by LPS after a preceding stimulation. LPS is recognized by Toll-like receptor-4 (TLR-4), which belongs to a group of pattern recognition receptors mediating activation of innate immunity by microbial components. To date, it is not known in detail to what extent other TLR-dependent stimuli also induce tolerance and whether preceding and challenging stimuli are interchangeable. We have examined tolerance induction in detail for lipoteichoic acid (LTA), LPS and CpG-DNA, which are recognized by TLR-2, -4 and -9, respectively. In RAW264.7 macrophages, all three stimuli induced tolerance towards a subsequent challenge with the same stimulus used for priming, as well as cross-tolerance towards subsequent challenge with other stimuli signalling via different TLRs. However, whereas LPS/LTA cross-tolerance was also functional in an in vivo model of galactosamine (GalN)-primed liver damage, pretreatment with CpG only protected against GalN/CpG challenge and failed to induce cross-tolerance for LPS and LTA. CpG-DNA pretreatment even enhanced tumour necrosis factor (TNF)-alpha production and liver damage upon subsequent challenge with LPS or LTA. Stimulation with CpG-DNA resulted in a peculiar sensitization for interferon (IFN)-gamma secretion. The data indicate that, in contrast to in vitro macrophage desensitization, the in vivo consequences of repeated TLR stimulation greatly differ amongst different TLR ligands.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16162269      PMCID: PMC1817820          DOI: 10.1111/j.1365-2567.2005.02211.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  49 in total

1.  A Toll-like receptor recognizes bacterial DNA.

Authors:  H Hemmi; O Takeuchi; T Kawai; T Kaisho; S Sato; H Sanjo; M Matsumoto; K Hoshino; H Wagner; K Takeda; S Akira
Journal:  Nature       Date:  2000-12-07       Impact factor: 49.962

2.  Induction of tolerance to lipopolysaccharide and mycobacterial components in Chinese hamster ovary/CD14 cells is not affected by overexpression of Toll-like receptors 2 or 4.

Authors:  A E Medvedev; P Henneke; A Schromm; E Lien; R Ingalls; M J Fenton; D T Golenbock; S N Vogel
Journal:  J Immunol       Date:  2001-08-15       Impact factor: 5.422

3.  A novel pathway regulating lipopolysaccharide-induced shock by ST2/T1 via inhibition of Toll-like receptor 4 expression.

Authors:  M J Sweet; B P Leung; D Kang; M Sogaard; K Schulz; V Trajkovic; C C Campbell; D Xu; F Y Liew
Journal:  J Immunol       Date:  2001-06-01       Impact factor: 5.422

4.  Inhibition of lipopolysaccharide-induced signal transduction in endotoxin-tolerized mouse macrophages: dysregulation of cytokine, chemokine, and toll-like receptor 2 and 4 gene expression.

Authors:  A E Medvedev; K M Kopydlowski; S N Vogel
Journal:  J Immunol       Date:  2000-06-01       Impact factor: 5.422

5.  Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition.

Authors:  S Bauer; C J Kirschning; H Häcker; V Redecke; S Hausmann; S Akira; H Wagner; G B Lipford
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-24       Impact factor: 11.205

6.  Differential regulation of the IL-12 p40 promoter and of p40 secretion by CpG DNA and lipopolysaccharide.

Authors:  J S Cowdery; N J Boerth; L A Norian; P S Myung; G A Koretzky
Journal:  J Immunol       Date:  1999-06-01       Impact factor: 5.422

7.  Induction of cross-tolerance by lipopolysaccharide and highly purified lipoteichoic acid via different Toll-like receptors independent of paracrine mediators.

Authors:  M D Lehner; S Morath; K S Michelsen; R R Schumann; T Hartung
Journal:  J Immunol       Date:  2001-04-15       Impact factor: 5.422

8.  Preexposure of murine macrophages to CpG oligonucleotide results in a biphasic tumor necrosis factor alpha response to subsequent lipopolysaccharide challenge.

Authors:  T D Crabtree; L Jin; D P Raymond; S J Pelletier; C W Houlgrave; T G Gleason; T L Pruett; R G Sawyer
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

9.  Cutting edge: endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface toll-like receptor 4 expression.

Authors:  F Nomura; S Akashi; Y Sakao; S Sato; T Kawai; M Matsumoto; K Nakanishi; M Kimoto; K Miyake; K Takeda; S Akira
Journal:  J Immunol       Date:  2000-04-01       Impact factor: 5.422

10.  Synergy and cross-tolerance between toll-like receptor (TLR) 2- and TLR4-mediated signaling pathways.

Authors:  S Sato; F Nomura; T Kawai; O Takeuchi; P F Mühlradt; K Takeda; S Akira
Journal:  J Immunol       Date:  2000-12-15       Impact factor: 5.422

View more
  40 in total

1.  Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice.

Authors:  Kouichi Miura; Yuzo Kodama; Sayaka Inokuchi; Bernd Schnabl; Tomonori Aoyama; Hirohide Ohnishi; Jerrold M Olefsky; David A Brenner; Ekihiro Seki
Journal:  Gastroenterology       Date:  2010-03-27       Impact factor: 22.682

Review 2.  Toll-like receptors and lupus nephritis.

Authors:  Fabrizio Conti; Francesca Romana Spinelli; Cristiano Alessandri; Guido Valesini
Journal:  Clin Rev Allergy Immunol       Date:  2011-06       Impact factor: 8.667

3.  Mechanistic role of microRNA-146a in endotoxin-induced differential cross-regulation of TLR signaling.

Authors:  Md A Nahid; Minoru Satoh; Edward K L Chan
Journal:  J Immunol       Date:  2010-12-22       Impact factor: 5.422

Review 4.  Immunobiology of the TAM receptors.

Authors:  Greg Lemke; Carla V Rothlin
Journal:  Nat Rev Immunol       Date:  2008-05       Impact factor: 53.106

Review 5.  Toll-like receptor signaling in endogenous neuroprotection and stroke.

Authors:  B J Marsh; R L Williams-Karnesky; M P Stenzel-Poore
Journal:  Neuroscience       Date:  2008-08-12       Impact factor: 3.590

6.  The synthetic triterpenoid, CDDO-Me, modulates the proinflammatory response to in vivo lipopolysaccharide challenge.

Authors:  Jeffery J Auletta; Jennifer L Alabran; Byung-Gyu Kim; Colin J Meyer; John J Letterio
Journal:  J Interferon Cytokine Res       Date:  2010-07       Impact factor: 2.607

Review 7.  The role of innate immunity in HBV infection.

Authors:  Qiuju Han; Cai Zhang; Jian Zhang; Zhigang Tian
Journal:  Semin Immunopathol       Date:  2012-07-20       Impact factor: 9.623

8.  Toll-like receptor 9-dependent macrophage activation by Entamoeba histolytica DNA.

Authors:  Catherine P A Ivory; Michael Prystajecky; Christian Jobin; Kris Chadee
Journal:  Infect Immun       Date:  2007-11-05       Impact factor: 3.441

9.  Prevention of autoimmune disease by induction of tolerance to Toll-like receptor 7.

Authors:  Tomoko Hayashi; Christine S Gray; Michael Chan; Rommel I Tawatao; Lisa Ronacher; Maureen A McGargill; Sandip K Datta; Dennis A Carson; Maripat Corr
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-02       Impact factor: 11.205

10.  Inadequate clearance of translocated bacterial products in HIV-infected humanized mice.

Authors:  Ursula Hofer; Erika Schlaepfer; Stefan Baenziger; Marc Nischang; Stephan Regenass; Reto Schwendener; Werner Kempf; David Nadal; Roberto F Speck
Journal:  PLoS Pathog       Date:  2010-04-29       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.